摘要
目的研究良性前列腺增生及膀胱肿瘤应用经尿道等离子体双极电切术的治疗效果。方法 60例良性前列腺增生患者和40例膀胱肿瘤患者采用计算机随机分为对照组和观察组,每组50例。对照组实施经尿道前列腺电切术治疗,观察组采用经尿道等离子体双极电切术治疗。对比两组患者的手术时间、术中出血量、住院时间以及并发症发生情况。结果观察组良性前列腺增生患者和膀胱肿瘤患者的手术时间、术中出血量和住院时间均优于对照组,差异具有统计学意义(P<0.05)。观察组良性前列腺增生患者并发症发生率为16.67%;膀胱肿瘤患者并发症发生率为10.00%;对照组良性前列腺增生患者并发症发生率为46.67%;膀胱肿瘤患者并发症发生率为50.00%,两组患者并发症发生率比较差异具有统计学意义(P<0.05)。结论经尿道等离子体双极电切术在治疗良性前列腺增生及膀胱肿瘤上的效果优越,可在临床推广。
Objective To research curative effect by transuretha plasmakinetic prostatectomy in the treatment of benign prostatic hyperplasia and bladder tumor. Methods A total of 60 patients with benign prostatic hyperplasia and dO patients with bladder tumor were randomly divided into control group and observation group, with 50 cases in each group. The control group received transurethral resection of prostate for treatment, and the observation group received transuretha plasmakinetic prostatectomy for treatment. Comparison was made on operation time, intraoperative bleeding volume, hospital stay time and complications between the two groups. Results The observation group had all better operation time, intraoperative bleeding volume, and hospital stay time in benign prostatic hyperplasia patients and bladder tumor patients than the control group, and their difference had statistical significance （P〈0.05）. Incidence of complications was 16.67% in benign prostatic hyperplasia patients and 10.00% in bladder tumor patients of the observation group. The control group had incidence of complications as 46.67% in benign prostatic hyperplasia patients and 50.00% in bladder tumor patients. Their difference of incidence of complications had statistical significance （P〈0.05）. Conclusion Transuretha plasmakinetic prostatectomy provides excellent effect in treating benign prostatic hyperplasia and bladder tumor, and it is worth clinical promotion.
作者
沈中伟
杨波
SHEN Zhong-wei YANG Bo(Liaoning Heishan County First People＇s Hospital, Jinzhou 121400, China)
出处
《中国实用医药》
2017年第7期57-59,共3页
China Practical Medicine
